NCT06909123View on ClinicalTrials.gov

A Reduced Dose of Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

July 31, 2026

Conditions
Lactation Suppressed
Interventions
DRUG

Cabergoline

Cabergoline

All Listed Sponsors
lead

Stanford University

OTHER